1. Home
  2. Browse
  3. Gastroenterology
  4. Liver Disease
  5. Monitoring

Monitoring

16 - 28 of 28 Results
Sort Results:
Article: Aubagio (oh-BAH-gee-oh, teriflunomide), the third ORAL option for relapsing forms of multiple sclerosis (MS) February 2014
Article: controversy about what works to prevent contrast-induced nephropathy December 2013
Article: myths about using meds in chronic liver disease October 2013
PL Voices: Myths About Medication Use in Chronic Liver Disease October 2013
Commentary: New Drug: Tecfidera (Dimethyl Fumarate) June 2013
Article: the second ORAL drug for relapsing-remitting multiple sclerosis (MS), Tecfidera (TEK-fi-de-rah, dimethyl fumarate) June 2013
Article: fewer liver function tests for patients on statins May 2012
PL Voices: When to Monitor Liver Enzymes for Patients Taking Statins May 2012
Article: whether it's okay for patients with elevated liver enzymes to take a statin January 2011
Commentary: Statins and the Liver January 2011
Article: what lab tests are needed for certain drugs July 2010
Article: risk of renal impairment in patients taking an ACE inhibitor or ARB, diuretic, and NSAID December 2006
Article: continued emphasis on preventing drug-induced liver disease December 2005